PTC Therapeutics Aktie
54,00
EUR
-1,00
EUR
-1,82
%
62,69
USD
-1,55
USD
-2,41
%
Werbung
PTC Therapeutics Aktie Analyse
| 04.04.18 | PTC Therapeutics Underweight | Barclays Capital |
Werbung
Werbung